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PrevalenceBackground: Drug resistance is the major problem in tuberculosis (TB) treatment and con-
trol. In the present study, it was decided to consider the prevalence and distribution of
multi-drug resistance Mycobacterium tuberculosis (MDR-TB) in Iran using meta-analysis
based on systematic review of articles published, which will provide more detailed infor-
mation to clearly overview the status of TB.
Methods: All original articles published in literature database including PubMed, Sciencedi-
rect, Web of Science, Google Scholar, Biological abs, Iranmedex, and SID systematically
reviewed the prevalence of MDR-TB. The summarized data has been analyzed statistically.
Results: Final analyses included 39 samples that have been selected from 535 studies. Over-
all MDR-TB prevalence in Iran was estimated to be 0.15 (95% CI = 0.14–0.16). Corresponding
estimates by city were Mashhad 0.22 (95% CI = 0.18–0.27), Tehran 0.16 (95% CI = 0.15–0.17),
and Zahedan 0.10 (95% CI = 0.07–0.15). In 2003 there was a high report of MDR-TB 0.88
(95% CI = 0.75–0.96).
Conclusions: According to the results, prevalence of MDR-TB in Iran is lower than worldwide
WHO report. Effective control program is needed in order to control and eradicate the
spread of drug resistance strains.
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